News Legal Alert life sciences Publications
Monday April 19th, 2021
Sorry, this entry is only available in Polish.
Sorry, this entry is only available in Polish.
Sołtysiński Kawecki & Szlęzak advised the owners of Nesperta on a sale transaction of a majority shareholding in the company…
At the end of June, the European Commission (EC) published an updated “Blue Guide”, which, first published in 2000, has…
Electronic cigarettes, especially disposable ones, have recently been the subject of public debate, primarily due to the announcement of restrictions…
The NSA allows the sale of alcohol over the Internet The Supreme Administrative Court (NSA), in a judgment dated September…
We are pleased to inform that veterinary clinic “Wróblewscy” located in Dąbrowa Górnicza has joined AniCura, a family of leading…
We have been recommended as one of the best law firms in 14 categories by The Legal500 EMEA 2024 ranking,…
SK&S’ transaction team has advised AniCura AB in the acquisition process of veterinary clinic “Centrum Zdrowia Małych Zwierząt” in Poznań,…
We are pleased to announce that the „International Advertising Law: A Practical Global Guide – Second Edition” has been published by…
”Advertising is the key to business success” is a saying that has been known for many years. Actions aimed at…
On March 21, 2023, the long-awaited act on clinical trials of medicinal products for human use was signed by the…
The introduction of Regulation (EU) 2017/745 on Medical Devices (“MDR”) gave rise to a number of questions regarding products which…
DISTRIBUTION Possible ’faster’ export/sale of products included on the list of products facing potential shortages in Poland. The Main Pharmaceutical Inspectorate (GIF) will be able…
“Sugars occurring naturally in beverages are not subject to the fee on foodstuffs and, as a result, their quantity (content)…
On April 10, 2024, the European Parliament adopted an update of four of the seven so-called “breakfast directives”[1] – directives…
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…